Department of Pediatrics, Renal Division, Houston, TX 77030, USA.
Clin J Am Soc Nephrol. 2009 Dec;4(12):1939-43. doi: 10.2215/CJN.02770409. Epub 2009 Oct 9.
Peritoneal dialysis (PD) is a common maintenance renal replacement modality for children with ESRD frequently compromised by infectious peritonitis and catheter exit site and tunnel infections (ESI/TI). The effect of topical mupirocin (Mup) and sodium hypochlorite (NaOCl) solution was evaluated as part of routine daily exit site care on peritonitis and ESI/TI rates, causative microorganisms, and catheter survival rates.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Retrospective chart review of children on home continuous cycling PD between April 1, 2001 and June 30, 2007 was performed. Infection rates were examined based on exit site protocol used in two different periods: Mup alone, April 1, 2001 to November 17, 2004; and Mup and NaOCl (Mup+NaOCl), November 18, 2004 to June 30, 2007.
Eighty-three patients (mean PD initiation age: 12.1 +/- 5.8 yr) received home PD over 2009 patient months. Annualized rates (ARs) for peritonitis decreased from 1.2 in the Mup period to 0.26 in the Mup+NaOCl period (P < 0.0001). ARs for ESI/TI decreased from 1.36 in the Mup period to 0.33 in the Mup+NaOCl period (P < 0.0001). No infections with Mup-resistant organisms were observed when either Mup or Mup+NaOCl was used for prophylaxis. Gram-negative-organism associated peritonitis decreased from an AR of 0.31 in the Mup period to 0.07 in the Mup+NaOCl period (P < 0.001). Infection-related catheter removal rates decreased from 1 in 38.9 catheter-months in the Mup period to 1 in 94.2 in the Mup+NaOCl period (P = 0.01). Catheter survival rates were longer in the Mup+NaOCl period (Kaplan-Meier, P < 0.009).
The combination Mup+NaOCl in daily exit site care was very effective to reduce PD catheter-associated infections and prolong catheter survival in pediatric patients.
腹膜透析(PD)是儿童终末期肾衰竭的常见维持性肾脏替代方式,常因感染性腹膜炎和导管出口部位及隧道感染(ESI/TI)而受到影响。评估局部莫匹罗星(Mup)和次氯酸钠(NaOCl)溶液作为日常出口部位护理的一部分,对腹膜炎和 ESI/TI 发生率、病原体和导管生存率的影响。
设计、设置、参与者和测量:对 2001 年 4 月 1 日至 2007 年 6 月 30 日期间接受家庭连续循环 PD 的儿童进行回顾性图表审查。根据两种不同时期使用的出口部位方案检查感染率:单独使用 Mup(2001 年 4 月 1 日至 2004 年 11 月 17 日);和 Mup+NaOCl(Mup+NaOCl)(2004 年 11 月 18 日至 2007 年 6 月 30 日)。
83 名患者(PD 起始年龄平均:12.1 +/- 5.8 岁)接受家庭 PD 治疗,共 2009 个患者月。腹膜炎的年发生率(AR)从 Mup 期的 1.2 降至 Mup+NaOCl 期的 0.26(P < 0.0001)。ESI/TI 的 AR 从 Mup 期的 1.36 降至 Mup+NaOCl 期的 0.33(P < 0.0001)。当使用 Mup 或 Mup+NaOCl 进行预防时,均未观察到对 Mup 耐药的生物体感染。革兰氏阴性菌相关腹膜炎的 AR 从 Mup 期的 0.31 降至 Mup+NaOCl 期的 0.07(P < 0.001)。与感染相关的导管去除率从 Mup 期的每 38.9 个导管月 1 例降至 Mup+NaOCl 期的每 94.2 个导管月 1 例(P = 0.01)。Mup+NaOCl 期间导管生存率更长(Kaplan-Meier,P < 0.009)。
在日常出口部位护理中,Mup+NaOCl 的联合使用可有效降低儿科患者 PD 导管相关感染和延长导管生存时间。